WW International, Inc. (NASDAQ: WW) and its affiliated medical groups ("Weight Watchers"), the global leader in science-backed weight management, is now accessible via Eli Lilly and Company's digital healthcare platform, LillyDirect®. This news further reflects Weight Watchers' continued focus on expanding access to trusted, brand-name GLP-1 medications paired with comprehensive clinical and behavioral support, designed for real life.